Lucentis 0.5 MG/0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBTFL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,461
Award facts
- Contract value 100% obligated
- $4,460.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,460.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its established small business status to distribute comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) awarded through the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions the contractor as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The contractor's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTFL?
SPE2DR26FBTFL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FBTFL worth?
The government has obligated $4,461 on SPE2DR26FBTFL.
Is contract SPE2DR26FBTFL an order under another contract?
Yes. SPE2DR26FBTFL is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTFL competed?
The extent of competition for SPE2DR26FBTFL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award